Fundz Deep Dive
Everything you need to win Jean-Baptiste (JB) Agnus — in one platform.
Who to reach, what to say, and why now on Jean-Baptiste (JB) Agnus — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Jean-Baptiste (JB) Agnus — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Kbiバイオファーマ・インコーポレーテッド Appoints Jean Baptiste (Jb) Agnus As Chief Business Officer (CBO)
PRIVATEApr 16, 2024•about 2 years ago
Position
Chief Business Officer
Company
KBIバイオファーマ・インコーポレーテッド
Description
KBIバイオファーマ・インコーポレーテッド（以下KBI）は、Jean-Baptiste (JB) Agnus氏を最高業務責任者（CBO）に指名し、当社の経営陣を固めることを発表しました。JB氏はバイオ医薬品業界のあらゆる分野での20年以上の経験があり、バイオ医薬品、低分子原薬、抗体薬物複合体（ADC）、細胞・遺伝子治療の最新の進歩における商業開発の知識を有しています。
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months